Cargando…

Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer

BACKGROUND: Constipation is a common side effect of opioid therapy. An observational study of opioid-induced constipation (OIC) in Japanese patients with cancer (OIC-J) included 212 patients with various tumor types. This post hoc analysis of OIC-J evaluated a subgroup of patients with gastrointesti...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Toshiyuki, Imai, Hisao, Fumita, Soichi, Noriyuki, Toshio, Gamoh, Makio, Okamoto, Masaharu, Akashi, Yusaku, Kizawa, Yoshiyuki, Tokoro, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788034/
https://www.ncbi.nlm.nih.gov/pubmed/33068220
http://dx.doi.org/10.1007/s10147-020-01790-y
_version_ 1783632949951856640
author Harada, Toshiyuki
Imai, Hisao
Fumita, Soichi
Noriyuki, Toshio
Gamoh, Makio
Okamoto, Masaharu
Akashi, Yusaku
Kizawa, Yoshiyuki
Tokoro, Akihiro
author_facet Harada, Toshiyuki
Imai, Hisao
Fumita, Soichi
Noriyuki, Toshio
Gamoh, Makio
Okamoto, Masaharu
Akashi, Yusaku
Kizawa, Yoshiyuki
Tokoro, Akihiro
author_sort Harada, Toshiyuki
collection PubMed
description BACKGROUND: Constipation is a common side effect of opioid therapy. An observational study of opioid-induced constipation (OIC) in Japanese patients with cancer (OIC-J) included 212 patients with various tumor types. This post hoc analysis of OIC-J evaluated a subgroup of patients with gastrointestinal (GI) cancer. METHODS: Patients were aged ≥ 20 years, starting strong opioid therapy, had an ECOG PS of ≤ 2, and must have had ≥ 3 bowel movements during the week before enrollment. OIC was evaluated for 2 weeks after opioid initiation using the Rome IV diagnostic criteria for colorectal disorders, as well as physician’s diagnosis, number of spontaneous bowel movements, Bowel Function Index score, and patient’s self-assessment. Relationships between baseline characteristics and OIC incidence, and the effects of OIC on quality of life (QOL) were also explored. RESULTS: Fifty patients from OIC-J who had GI cancer [colon (50%), stomach (28%), and esophageal (22%)] were included. OIC incidence varied by which diagnostic criteria were used (46.0–62.0%) and occurred rapidly after initiating opioid therapy. The use of prophylactic laxatives reduced the overall incidence rate of OIC from 71.0% to 47.4%. No baseline characteristics, except comorbidities, were associated with OIC incidence. Change from baseline to day 15 in PAC-SYM total score was significantly greater for patients with OIC versus those without OIC (0.188 versus −0.362; P = 0.0011). CONCLUSIONS: This post hoc analysis suggests that OIC occurs rapidly in patients with GI cancer after initiating opioid therapy, and negatively impacts QOL. Early and effective intervention strategies may be particularly useful in this group. ADDITIONAL INFORMATION: Coauthor Makio Gamoh is deceased. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10147-020-01790-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7788034
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-77880342021-01-14 Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer Harada, Toshiyuki Imai, Hisao Fumita, Soichi Noriyuki, Toshio Gamoh, Makio Okamoto, Masaharu Akashi, Yusaku Kizawa, Yoshiyuki Tokoro, Akihiro Int J Clin Oncol Original Article BACKGROUND: Constipation is a common side effect of opioid therapy. An observational study of opioid-induced constipation (OIC) in Japanese patients with cancer (OIC-J) included 212 patients with various tumor types. This post hoc analysis of OIC-J evaluated a subgroup of patients with gastrointestinal (GI) cancer. METHODS: Patients were aged ≥ 20 years, starting strong opioid therapy, had an ECOG PS of ≤ 2, and must have had ≥ 3 bowel movements during the week before enrollment. OIC was evaluated for 2 weeks after opioid initiation using the Rome IV diagnostic criteria for colorectal disorders, as well as physician’s diagnosis, number of spontaneous bowel movements, Bowel Function Index score, and patient’s self-assessment. Relationships between baseline characteristics and OIC incidence, and the effects of OIC on quality of life (QOL) were also explored. RESULTS: Fifty patients from OIC-J who had GI cancer [colon (50%), stomach (28%), and esophageal (22%)] were included. OIC incidence varied by which diagnostic criteria were used (46.0–62.0%) and occurred rapidly after initiating opioid therapy. The use of prophylactic laxatives reduced the overall incidence rate of OIC from 71.0% to 47.4%. No baseline characteristics, except comorbidities, were associated with OIC incidence. Change from baseline to day 15 in PAC-SYM total score was significantly greater for patients with OIC versus those without OIC (0.188 versus −0.362; P = 0.0011). CONCLUSIONS: This post hoc analysis suggests that OIC occurs rapidly in patients with GI cancer after initiating opioid therapy, and negatively impacts QOL. Early and effective intervention strategies may be particularly useful in this group. ADDITIONAL INFORMATION: Coauthor Makio Gamoh is deceased. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10147-020-01790-y) contains supplementary material, which is available to authorized users. Springer Singapore 2020-10-17 2021 /pmc/articles/PMC7788034/ /pubmed/33068220 http://dx.doi.org/10.1007/s10147-020-01790-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Harada, Toshiyuki
Imai, Hisao
Fumita, Soichi
Noriyuki, Toshio
Gamoh, Makio
Okamoto, Masaharu
Akashi, Yusaku
Kizawa, Yoshiyuki
Tokoro, Akihiro
Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer
title Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer
title_full Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer
title_fullStr Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer
title_full_unstemmed Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer
title_short Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer
title_sort opioid-induced constipation in patients with cancer pain in japan (oic-j study): a post hoc subgroup analysis of patients with gastrointestinal cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788034/
https://www.ncbi.nlm.nih.gov/pubmed/33068220
http://dx.doi.org/10.1007/s10147-020-01790-y
work_keys_str_mv AT haradatoshiyuki opioidinducedconstipationinpatientswithcancerpaininjapanoicjstudyaposthocsubgroupanalysisofpatientswithgastrointestinalcancer
AT imaihisao opioidinducedconstipationinpatientswithcancerpaininjapanoicjstudyaposthocsubgroupanalysisofpatientswithgastrointestinalcancer
AT fumitasoichi opioidinducedconstipationinpatientswithcancerpaininjapanoicjstudyaposthocsubgroupanalysisofpatientswithgastrointestinalcancer
AT noriyukitoshio opioidinducedconstipationinpatientswithcancerpaininjapanoicjstudyaposthocsubgroupanalysisofpatientswithgastrointestinalcancer
AT gamohmakio opioidinducedconstipationinpatientswithcancerpaininjapanoicjstudyaposthocsubgroupanalysisofpatientswithgastrointestinalcancer
AT okamotomasaharu opioidinducedconstipationinpatientswithcancerpaininjapanoicjstudyaposthocsubgroupanalysisofpatientswithgastrointestinalcancer
AT akashiyusaku opioidinducedconstipationinpatientswithcancerpaininjapanoicjstudyaposthocsubgroupanalysisofpatientswithgastrointestinalcancer
AT kizawayoshiyuki opioidinducedconstipationinpatientswithcancerpaininjapanoicjstudyaposthocsubgroupanalysisofpatientswithgastrointestinalcancer
AT tokoroakihiro opioidinducedconstipationinpatientswithcancerpaininjapanoicjstudyaposthocsubgroupanalysisofpatientswithgastrointestinalcancer